AI assistant
Sending…
ASSEMBLY BIOSCIENCES, INC. — Director's Dealing 2021
May 24, 2021
33081_dirs_2021-05-24_f52dcff6-e9b2-4488-a28b-eda2bfb4d71e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK: 0001426800
Period of Report: 2021-05-20
Reporting Person: Consylman Gina (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-05-20 | Stock Option (right to buy) | $4.03 | A | 15000 | Acquired | 2031-05-20 | Common Stock (15000) | Direct |
Footnotes
F1: Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 20, 2022 and (2) the date of the Issuer's 2022 annual meeting of stockholders.
More from ASSEMBLY BIOSCIENCES, INC.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 5
Capital/Financing Update
2026
May 26
Share Issue/Capital Change
2026
May 22
Capital/Financing Update
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
Mar 30
Capital/Financing Update
2026
Mar 19
Regulatory Filings
2026
Mar 19
Major Shareholding Notification
2026
Feb 9
Regulatory Filings
2025
Dec 8